Archives: Seminars

Does tobacco harm reduction (THR) compliment or undermine core tobacco control principles?

What hostile and supportive forces are bearing on the transitions to low-risk alternatives to smoking? Are we about to squander the opportunity to avoid millions of premature deaths and cases of disease through a dogmatic refusal to embrace innovation and harm reduction? Or will the fundamentals of risk and personal agency and autonomy ultimately prevail? … Read more »

Definitions of THR have evolved since the late 70s and more recently includes targeting people who cannot or don’t want to quit nicotine. Those who cannot or do not want to quit nicotine tends to be people with mental health and substance use problems, but also those in routine and manual occupations, those living in… Read more »

Australia is one of the only English-speaking, high-income countries that has banned the sale of e-cigarettes as consumer products. Until 1 October 2021, smokers could legally import nicotine for personal use with prescription. Most smokers imported nicotine illegally because very few doctors were prepared to prescribe nicotine. The use of e-cigarettes increased among Australian smokers… Read more »

The prevalence of tobacco smoking in Germany is still at a very high level (nearly 30%), and the use of alternative nicotine delivery systems (ANDS) has been increasing in the population. The World Health Organisation (WHO) recommends monitoring the use of tobacco and ANDS on a national level to support implementation of the WHO Framework… Read more »

In some countries, like Norway and Sweden, the level of smoking has reached a minimum – in particular among young adults below the age of 25 where the prevalence of smoking is approximately 2%. Availability to snus in combination with a robust infrastructure for tobacco control are the main reasons. In these markets snus has… Read more »